OSIRIS THERAPEUTICS, INC. — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/760495b1-d82e-42e8-ae00-683af580f062/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2018 | $142.8M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-002094 |
| FY 2017 | $118.5M | 2017-01-01 – 2017-12-31 | evidence 0001558370-19-002094 |
| FY 2016 | $109.4M | 2016-01-01 – 2016-12-31 | evidence 0001047469-18-002273 |
| FY 2015 | $79.7M | 2015-01-01 – 2015-12-31 | evidence 0001047469-18-002273 |
| FY 2014 | $50.8M | 2014-01-01 – 2014-12-31 | evidence 0001104659-17-019408 |
| FY 2013 | $25.7M | 2013-01-01 – 2013-12-31 | evidence 0001104659-17-019408 |
| FY 2012 | $7.2M | 2012-01-01 – 2012-12-31 | evidence 0001104659-17-019408 |
| FY 2011 | $1.3M | 2011-01-01 – 2011-12-31 | evidence 0001047469-13-002788 |
| FY 2010 | $183.0k | 2010-01-01 – 2010-12-31 | evidence 0001047469-13-002788 |
| FY 2009 | $44.5M | 2009-01-01 – 2009-12-31 | evidence 0001047469-12-002580 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).